Literature DB >> 3873366

Opposite regulation of pro-opiomelanocortin gene transcription by glucocorticoids and CRH.

J P Gagner, J Drouin.   

Abstract

Pro-opiomelanocortin (POMC) is the pituitary precursor for adrenocorticotropin (ACTH), beta-endorphin, beta-lipotropin and the melanotropins. The level of ACTH secretion from the anterior pituitary is largely determined by the competing action of the stimulatory hypothalamic hormone, corticoliberin (corticotropin-releasing hormone, CRH), and the inhibitory effect of glucocorticoids. We now demonstrate that these two hormones, glucocorticoids and CRH, also inhibit and stimulate, respectively, the transcription rate of the POMC gene as measured by nuclear run-on transcription assays. Indeed, we show both by in vivo treatment and with rat anterior pituitary cells in primary culture that glucocorticoids inhibit within 30 min transcription of the POMC gene. Similarly, we find that CRH stimulates POMC gene transcription within 15 min. CRH and glucocorticoids can compete with each other to set the rate of POMC transcription. Our results indicate that CRH and glucocorticoids regulate anterior pituitary POMC gene transcription in addition to their well-documented role in the control of POMC peptide release.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3873366     DOI: 10.1016/0303-7207(85)90154-6

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  25 in total

1.  Structure of the gene encoding VGF, a nervous system-specific mRNA that is rapidly and selectively induced by nerve growth factor in PC12 cells.

Authors:  S R Salton; D J Fischberg; K W Dong
Journal:  Mol Cell Biol       Date:  1991-05       Impact factor: 4.272

2.  Antagonism between Nur77 and glucocorticoid receptor for control of transcription.

Authors:  A Philips; M Maira; A Mullick; M Chamberland; S Lesage; P Hugo; J Drouin
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

3.  Novel dimeric Nur77 signaling mechanism in endocrine and lymphoid cells.

Authors:  A Philips; S Lesage; R Gingras; M H Maira; Y Gauthier; P Hugo; J Drouin
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

4.  Role of Brg1 and HDAC2 in GR trans-repression of the pituitary POMC gene and misexpression in Cushing disease.

Authors:  Steve Bilodeau; Sophie Vallette-Kasic; Yves Gauthier; Dominique Figarella-Branger; Thierry Brue; France Berthelet; André Lacroix; Dalia Batista; Constantine Stratakis; Jeanette Hanson; Björn Meij; Jacques Drouin
Journal:  Genes Dev       Date:  2006-10-15       Impact factor: 11.361

5.  Pituitary-specific expression and glucocorticoid regulation of a proopiomelanocortin fusion gene in transgenic mice.

Authors:  Y Tremblay; I Tretjakoff; A Peterson; T Antakly; C X Zhang; J Drouin
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

6.  Glucocorticoid inhibition of transcription from episomal proopiomelanocortin gene promoter.

Authors:  J Charron; J Drouin
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

Review 7.  Nuclear receptors in inflammation control: repression by GR and beyond.

Authors:  Yurii Chinenov; Rebecca Gupte; Inez Rogatsky
Journal:  Mol Cell Endocrinol       Date:  2013-04-26       Impact factor: 4.102

Review 8.  POMC: The Physiological Power of Hormone Processing.

Authors:  Erika Harno; Thanuja Gali Ramamoorthy; Anthony P Coll; Anne White
Journal:  Physiol Rev       Date:  2018-10-01       Impact factor: 37.312

9.  A novel transcriptional activator (PO-B) binds between the TATA box and cap site of the pro-opiomelanocortin gene.

Authors:  A T Riegel; J Remenick; R G Wolford; D S Berard; G L Hager
Journal:  Nucleic Acids Res       Date:  1990-08-11       Impact factor: 16.971

10.  Independent glucocorticoid induction and repression of two contiguous responsive genes.

Authors:  J Charron; H Richard-Foy; D S Berard; G L Hager; J Drouin
Journal:  Mol Cell Biol       Date:  1989-07       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.